CN115462429A - Multifunctional health tea composition - Google Patents

Multifunctional health tea composition Download PDF

Info

Publication number
CN115462429A
CN115462429A CN202211123122.0A CN202211123122A CN115462429A CN 115462429 A CN115462429 A CN 115462429A CN 202211123122 A CN202211123122 A CN 202211123122A CN 115462429 A CN115462429 A CN 115462429A
Authority
CN
China
Prior art keywords
parts
improving
cistanche
multifunctional health
liquorice
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202211123122.0A
Other languages
Chinese (zh)
Inventor
雷琼芳
汤国良
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Tangjia Health Management Co ltd
Original Assignee
Guangzhou Tangjia Health Management Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Tangjia Health Management Co ltd filed Critical Guangzhou Tangjia Health Management Co ltd
Priority to CN202211123122.0A priority Critical patent/CN115462429A/en
Publication of CN115462429A publication Critical patent/CN115462429A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/34Tea substitutes, e.g. matè; Extracts or infusions thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/076Poria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/64Orobanchaceae (Broom-rape family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/72Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725Ziziphus, e.g. jujube
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • A61K36/746Morinda
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815Lycium (desert-thorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8968Ophiopogon (Lilyturf)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/898Orchidaceae (Orchid family)
    • A61K36/8984Dendrobium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Food Science & Technology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)

Abstract

The invention relates to the technical field of health preserving videos, and particularly relates to a multifunctional health preserving tea composition which comprises the following components in parts by weight: 2-4 parts of cistanche, 1-3 parts of eurycoma longifolia, 1-3 parts of dendrobium officinale, 1-3 parts of American ginseng, 0.5-2 parts of radix ophiopogonis, 1-2 parts of morinda officinalis, 3-6 parts of poria cocos, 2-5 parts of medlar, 0.5-2 parts of liquorice, 2-4 parts of spina date seeds and 1-3 parts of dried orange peel. The composition obtained by reasonably mixing the traditional Chinese medicine components has the effects of improving sleep, energy and immunity, improving ulcer, enhancing detoxification capability and regulating blood sugar. Improving kidney function, reducing uric acid, and reducing nocturia.

Description

Multifunctional health tea composition
Technical Field
The invention relates to the technical field of health food, in particular to a multifunctional health tea composition.
Background
Tea is one of the favorite drinks, common tea comprises black tea, green tea, fruit tea, milk tea and the like, hot tea can effectively regulate body functions, and some tea can even detoxify and resist cancers.
With the continuous improvement of the living standard of people, people pay more and more attention to health preservation, the body of people is conditioned by methods of movement, psychological adjustment, diet, massage and the like, in diet, the importance of tea is self-evident, early tea can maintain skin, eliminate fatigue, delay aging and the like, afternoon tea can enhance memory, prevent sterol rise and the like, and comprehensively, health tea can effectively prevent apoplexy, improve vascular function, promote the discharge of body toxins, enhance immunity, beautify the face and nourish the skin and the like, so the health tea has great market power in the future, and the creation of the health tea is paid more and more attention.
At present, health-care tea on the market mostly concentrates on one efficacy, has single functionality, and some health-care tea have over-strong functionality and are not suitable for some people to use.
Disclosure of Invention
The invention provides a multifunctional health tea composition in order to overcome the problems that health tea in the prior art is single in function and not suitable for all people.
The purpose of the invention is realized by the following technical scheme:
the multifunctional health tea composition comprises the following components in parts by weight: 2-4 parts of cistanche, 1-3 parts of eurycoma longifolia, 1-3 parts of dendrobium officinale, 1-3 parts of American ginseng, 0.5-2 parts of radix ophiopogonis, 1-2 parts of morinda officinalis, 3-6 parts of poria cocos, 2-5 parts of medlar, 0.5-2 parts of liquorice, 2-4 parts of spina date seeds and 1-3 parts of dried orange peel.
Preferably, the composition comprises the following components in parts by weight: 2.5-3.2 parts of cistanche, 1.2-2.7 parts of Eurycoma longifolia, 1.3-2.4 parts of dendrobium officinale, 1.2-2.8 parts of American ginseng, 0.8-1.8 parts of radix ophiopogonis, 1.2-1.9 parts of morinda officinalis, 2.8-5.8 parts of poria cocos, 2.2-4.6 parts of medlar, 0.8-1.7 parts of liquorice, 2.6-3.8 parts of spina date seeds and 1.2-2.6 parts of dried orange peel.
Preferably, the composition comprises the following components in parts by weight: the traditional Chinese medicine composition comprises, by weight, 2.8 parts of cistanche, 1.8 parts of eurycoma longifolia, 2.1 parts of dendrobium officinale, 2.6 parts of American ginseng, 1.2 parts of radix ophiopogonis, 1.8 parts of morinda officinalis, 4.2 parts of poria cocos, 3.8 parts of medlar, 1.5 parts of liquorice, 3.1 parts of spina date seeds and 2.3 parts of dried orange peel.
Cistanche has a certain anti-aging effect. Cistanchis herba can obviously enhance the activity of mouse erythrocyte superoxide dismutase (SOD) and obviously reduce the content of myocardial lipofuscin in mouse. The average life span, half the death days and the maximum life span of the fruit flies can also be prolonged. Can regulate the decrease and increase of nucleic acid content in liver and spleen of animals with yang deficiency and yin deficiency; has the effects of activating adrenal gland and releasing corticoid. Improving immunity, remarkably increasing weight of spleen and thymus, remarkably enhancing phagocytic ability of abdominal macrophage, increasing hemolysin and PFC value, and improving lymphocyte transformation rate and delayed hypersensitivity index.
Eurycoma longifolia has the effects of resisting tumors and malaria, improving male sexual dysfunction and the like. In addition, the extract also has the effects of improving physical strength, relieving fatigue, sterilizing, resisting ulcer, reducing blood pressure, treating diabetes and the like, and is one of the precious applied botanical drugs in southeast Asia.
Dendrobium officinale has the effect of promoting the production of body fluid, and is mainly characterized by promoting glandular secretion and organ movement. Can reduce streptozotocin induced diabetes blood sugar value. Can promote the phagocytic function of macrophages of tumor-bearing animals, enhance the proliferation and differentiation of T lymphocytes and the activity of NK cells, and obviously improve the serum hemolysin value of the tumor-bearing animals.
The American ginseng has the functions of tonifying qi and yin, clearing heat and promoting fluid production. Can be used for treating deficiency of qi and yin, internal heat, cough, asthma, phlegm blood, asthenia, fever, vexation, fatigue, diabetes, xerostomia, and dry throat. The American ginseng has the functions of resisting fatigue, promoting urination and resisting anoxia, has better curative effects on hypertension, myocardial malnutrition, coronary heart disease, angina and the like, can relieve adverse reactions caused by radiotherapy and chemotherapy for cancer patients, and has the functions of improving the strain state of the body, relieving thymus gland and lymphatic tissue atrophy, nourishing and strengthening, nourishing blood and promoting the production of body fluid, calming the nerves and improving intelligence.
Compared with the prior art, the invention has the following technical effects:
the multifunctional health-preserving traditional Chinese medicine composition disclosed by the invention has the effects of improving sleep, improving energy, improving immunity, improving ulcer, enhancing detoxification capability and regulating blood sugar by reasonably mixing the traditional Chinese medicine components. Improving kidney function, reducing uric acid, and reducing nocturia.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments; all other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention. The starting materials used in the examples are all commercially available, unless otherwise specified.
Example 1
The multifunctional health-preserving important composition comprises the following components in parts by weight: 2.8 parts of cistanche, 1.8 parts of eurycoma longifolia, 2.1 parts of dendrobium officinale, 2.6 parts of American ginseng, 1.2 parts of radix ophiopogonis, 1.8 parts of morinda officinalis, 4.2 parts of poria cocos, 3.8 parts of medlar, 1.5 parts of liquorice, 3.1 parts of spina date seeds, 2.3 parts of pericarpium citri reticulatae and 0.9 part of snow chrysanthemum.
Example 2
The multifunctional health-preserving important composition comprises the following components in parts by weight: the traditional Chinese medicine composition comprises, by weight, 2 parts of cistanche, 3 parts of eurycoma longifolia, 1 part of dendrobium officinale, 3 parts of American ginseng, 2 parts of radix ophiopogonis, 2 parts of morinda officinalis, 3 parts of poria cocos, 2 parts of wolfberry, 0.5 part of liquorice, 4 parts of spina date seeds, 1 part of pericarpium citri reticulatae and 0.5 part of coreopsis tinctoria.
Example 3
The multifunctional health-preserving important composition comprises the following components in parts by weight: 4 parts of cistanche, 1 part of eurycoma longifolia, 3 parts of dendrobium officinale, 1 part of American ginseng, 0.5 part of radix ophiopogonis, 1 part of morinda officinalis, 6 parts of poria cocos, 5 parts of medlar, 2 parts of liquorice, 2 parts of spina date seed, 3 parts of pericarpium citri reticulatae and 1.5 parts of coreopsis tinctoria.
Comparative example 1
Compared with example 1, cistanche salsa is not added in the comparative example.
Comparative example 2
In contrast to example 1, no Eurycoma longifolia was added to this comparative example.
Comparative example 3
Compared with example 1, dendrobium officinale is not added in the comparative example.
Comparative example 4
In comparison with example 1, no American ginseng was added in this comparative example.
Examples of the experiments
The health tea compositions of each example and comparative example were brewed with hot water for use by different people. The health tea is continuously used by people for 1 month, and the investigation results of the conditions of different people are shown in the following table.
Figure BDA0003847229820000041
As can be seen from the above table, the health tea composition of the example is advantageous in maintaining energy, providing immunity to the human body to reduce canker sores, and reducing blood glucose and uric acid. Is beneficial to improving the renal function, obviously reduces the nocturia times and improves the sleep quality.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.

Claims (3)

1. The multifunctional health-preserving tea composition is characterized by comprising the following components in parts by weight: 2-4 parts of cistanche, 1-3 parts of eurycoma longifolia, 1-3 parts of dendrobium officinale, 1-3 parts of American ginseng, 0.5-2 parts of radix ophiopogonis, 1-2 parts of morinda officinalis, 3-6 parts of poria cocos, 2-5 parts of medlar, 0.5-2 parts of liquorice, 2-4 parts of spina date seeds, 1-3 parts of pericarpium citri reticulatae and 0.5-1.5 parts of snow chrysanthemum.
2. The multifunctional health tea composition according to claim 1, comprising the following components in parts by weight: 2.5 to 3.2 parts of cistanche, 1.2 to 2.7 parts of Eurycoma longifolia, 1.3 to 2.4 parts of dendrobium officinale, 1.2 to 2.8 parts of American ginseng, 0.8 to 1.8 parts of dwarf lilyturf tuber, 1.2 to 1.9 parts of morinda officinalis, 2.8 to 5.8 parts of tuckahoe, 2.2 to 4.6 parts of medlar, 0.8 to 1.7 parts of liquorice, 2.6 to 3.8 parts of spina date seed, 1.2 to 2.6 parts of dried orange peel and 0.8 to 1.2 parts of snow chrysanthemum.
3. The multifunctional health tea composition according to claim 1, comprising the following components in parts by weight: 2.8 parts of cistanche, 1.8 parts of eurycoma longifolia, 2.1 parts of dendrobium officinale, 2.6 parts of American ginseng, 1.2 parts of radix ophiopogonis, 1.8 parts of morinda officinalis, 4.2 parts of poria cocos, 3.8 parts of medlar, 1.5 parts of liquorice, 3.1 parts of spina date seeds, 2.3 parts of pericarpium citri reticulatae and 0.9 part of snow chrysanthemum.
CN202211123122.0A 2022-09-15 2022-09-15 Multifunctional health tea composition Pending CN115462429A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211123122.0A CN115462429A (en) 2022-09-15 2022-09-15 Multifunctional health tea composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211123122.0A CN115462429A (en) 2022-09-15 2022-09-15 Multifunctional health tea composition

Publications (1)

Publication Number Publication Date
CN115462429A true CN115462429A (en) 2022-12-13

Family

ID=84332992

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211123122.0A Pending CN115462429A (en) 2022-09-15 2022-09-15 Multifunctional health tea composition

Country Status (1)

Country Link
CN (1) CN115462429A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105031204A (en) * 2015-08-27 2015-11-11 上海天慈国际药业有限公司 Tranquilizing health tea
CN105475783A (en) * 2015-11-30 2016-04-13 上海银源宝生物科技有限公司 Drink for nourishing yin and invigorating yang and preparation method thereof
CN106689569A (en) * 2015-11-17 2017-05-24 济南健康人药品有限公司 Eurycoma longifolia anti-fatigue health tea
CN106819280A (en) * 2016-12-27 2017-06-13 防城港市万景林业有限公司 Health tea formula prepared by a kind of use Tongkat Ali, Momordica grosvenori
CN106962549A (en) * 2017-01-23 2017-07-21 丰泽阿里控股(香港)有限公司 A kind of health preserving tea and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105031204A (en) * 2015-08-27 2015-11-11 上海天慈国际药业有限公司 Tranquilizing health tea
CN106689569A (en) * 2015-11-17 2017-05-24 济南健康人药品有限公司 Eurycoma longifolia anti-fatigue health tea
CN105475783A (en) * 2015-11-30 2016-04-13 上海银源宝生物科技有限公司 Drink for nourishing yin and invigorating yang and preparation method thereof
CN106819280A (en) * 2016-12-27 2017-06-13 防城港市万景林业有限公司 Health tea formula prepared by a kind of use Tongkat Ali, Momordica grosvenori
CN106962549A (en) * 2017-01-23 2017-07-21 丰泽阿里控股(香港)有限公司 A kind of health preserving tea and preparation method thereof

Similar Documents

Publication Publication Date Title
CN103285231B (en) Medicine composition for diabetes adjunctive therapy and preparation method thereof
CN104740308B (en) A kind of hypoglycemic oral liquid of medical bio and preparation method thereof
CN104082672B (en) A kind of health-preserving porridge with effect of lowering blood sugar and preparation method thereof
CN103169793B (en) Medicine for treating hypertension, hyperlipoidemia and diabetes mellitus
CN111110792A (en) Rhizoma polygonati and ginseng tea for controlling sugar, regulating lipid, reducing viscosity, preventing and treating diabetes and complications thereof
CN108887683A (en) A kind of rice additive and its preparation process and the raw rice of medicine nourishment maintenance that medicine nourishment maintenance is raw
CN115462429A (en) Multifunctional health tea composition
CN109393441A (en) A kind of chick-pea Inonotus obliquus composition and preparation method thereof
CN106819219A (en) A kind of compound tealeaves with blood-nourishing tonifying Qi effect
CN107019208A (en) A kind of Chinese medicine ferment and preparation method thereof
CN106860814B (en) Health food composition for improving female frequent micturition and urinary incontinence and preparation method and application thereof
CN110090282A (en) For mitigating the Chinese medicine composition of gastrointestinal tract toxicity
CN104544064A (en) Health food containing eaglewood leaves and having efficacy of reducing blood sugar and blood fat
CN107308266A (en) A kind of female health preserving health composition and preparation method and application
CN106692760A (en) Golden flower wine formula for preventing diabetes and preparation method thereof
CN102657277A (en) All natural tri-hypo-effects (hypoglycemic, hypolipaemic and hypotensive effects) tea
CN105582412A (en) Compound preparation for facilitating oncothlipsis postoperative healing and preparation method thereof
CN105343866A (en) Traditional Chinese medicine tablets for treating cold rheum coughs and preparation method
CN101081078A (en) Lotus seed ginkgo nut beverage
CN104984150A (en) Preparing technology of health maintaining porridge with blood pressure reducing effect
KR20050001730A (en) Composition for prevention and treatment of cancer
CN103349108A (en) Warming-yang and tonifying-pleen healthy team cream and preparation method
CN107029108A (en) A kind of anti-aging takes care of health the medicine food composition and its preparation of macrobiosis
CN107485680A (en) A kind of Chinese medicine for treating breast cancer
CN106344655A (en) Traditional Chinese medicinal composition with blood glucose reducing effect and manufacturing method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20221213

WD01 Invention patent application deemed withdrawn after publication